Robin Taylor
Corporate Officer/Principal bei AGENUS INC.
Profil
Robin G.
Taylor is currently the Chief Commercial Officer at Agenus, Inc. In 2019-2020, he held the same position at Seagen Inc. Taylor received his undergraduate degree from the University of British Columbia, his doctorate from the University of Toronto, and his MBA from the University of California, Berkeley.
Aktive Positionen von Robin Taylor
| Unternehmen | Position | Beginn |
|---|---|---|
| AGENUS INC. | Corporate Officer/Principal | 20.07.2023 |
Ehemalige bekannte Positionen von Robin Taylor
| Unternehmen | Position | Ende |
|---|---|---|
| SEAGEN INC. | Corporate Officer/Principal | 01.02.2020 |
Ausbildung von Robin Taylor
| University of British Columbia | Undergraduate Degree |
| University of Toronto | Doctorate Degree |
| University of California, Berkeley | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AGENUS INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
